第六章 討論
6.8 灌食沒食子酸對高果糖誘導高血糖大鼠腎周脂肪脂質代謝之影響
FAS能催化脂肪酸合成反應,屬於長期調控脂肪酸合成的限速酵素。研究指 出單醣類對FAS的調控,較複合糖類更具顯著影響 (Semenkovich, 1997)。本篇研 究結果顯示,HF組腎周脂肪內FAS蛋白表現量相較於Normal組,有稍微提高但沒 有顯著差異,給予沒食子酸30 mg/kg B.W.濃度下,相較於高果糖組明顯增加FAS
57 蛋白表現量,且達顯著差異。
b.脂肪細胞三酸甘油酯脂解酶(Adipose triglyceride lipase; ATGL)
游離脂肪酸主要由脂解酶分解三酸甘油酯而來,脂解功能異常將導致能量代 謝異常,引起肥胖及胰島素阻抗(Zimmermann et al., 2004)。體內主要分解 TG 的 脂解酶包括 HSL 與 ATGL。本篇研究顯示實驗動物灌食沒食子酸 6 週後,HF 組 ATGL 顯著低於 Normal 組,顯示高果糖誘導模式將會降低脂解作用。GA30 組顯 著高於 HF 組,但與 GA10 組沒有顯著差異,由此可知灌食沒食子酸 30 mg/kg B.W.
可顯著提升 ATGL 增加脂解作用,但灌食沒食子酸 10 mg/kg B.W.則沒有影響。
58 第七章 結論
本篇研究結果可歸納以下幾點結論:
1.灌食 30 mg/kg B.W.沒食子酸可有效改善高果糖飼料誘導高血糖 Wistar 大鼠高 血糖、高胰島素血症等現象。
2.灌食 30 mg/kg B.W.沒食子酸可有效降低高果糖飼料誘導高血糖 Wistar 大鼠體 脂肪及血漿中三酸甘油脂濃度。
3.灌食 30 mg/kg B.W.沒食子酸可藉由提高 Glut4、IR、PKC-ζ等胰島素訊息傳遞 蛋白,來改善高果糖飼料誘導高血糖 Wistar 大鼠葡萄糖代謝。
4.灌食 30 mg/kg B.W.沒食子酸可藉由提高 ATGL 蛋白表現量,來增加高果糖飼 料誘導高血糖 Wistar 大鼠三酸甘油酯分解,並降低體脂肪。
59
Normal HF HF+PIO30 HF+GA30 HF+GA10
Plasma insulin (mg/dl)
Figure.5-1 Oral glucose tolerance test (OGTT) curve on plasma glucose level of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.)
*: Indicates a signify difference (p<0.05) compared with the other group.
Values were calculated as mean±S.E for six rats in each group.
*
* *
*
*
60
Normal HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasm glucose(mg/dL)
0 50 100 150 200 250
圖 5-2 灌食沒食子酸 4 週後大鼠於禁食情況下血漿中葡萄糖濃度之變化。
Figure.5-2 Plasma glucose levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~b Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
a
b
b b
61
Normal HF HF+pio(30) HF+GA(30) HF+GA(10)
Fructosamine (umol/L)
0 20 40 60 80 100 120 140
圖 5-3 灌食沒食子酸 4 週後大鼠於禁食情況下血漿中果糖胺濃度之變化。
Figure.5-3 Plasma fructosamine levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
c
a
bc bc bc
62
Normal HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasma insulin mg/dL
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4
圖 5-4 灌食沒食子酸 4 週後大鼠於禁食情況下血漿中胰島素濃度之變化。
Figure.5-4 Plasma insulin levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~b Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
a
b
b b
63
NORMAL HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasma C-peptide(pmol/L)
0.00 0.02 0.04 0.06 0.08 0.10 0.12 0.14 0.16
圖 5-5 灌食沒食子酸 4 週後大鼠於禁食情況下血漿中
C 胜鏈濃度之變化。
Figure.5-5 Plasma C-peptide levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
bc
a
bc
c
bc
64
Normal HF HF+Pio(30) HF+GA(30) HF+GA(10)
Adipose tissue (g)
0 2 4 6 8 10 12 14
圖 5-6 灌食沒食子酸 4 週後大鼠體內脂肪組織堆積之變化。
Figure.5-6 Adipose tissue accumulation of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~b Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
a
b
b
b
65
Normal HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasma triglyceride (mg/dL)
Figure.5-7 Plasma triglyceride levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ) Values were calculated as mean±S.E for six rats in each group.
bc
a
b
c
bc
66
CTR HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasma free fatty acid (mmol/L)
0.0
Figure.5-8 Plasma free fatty acid levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ) Values were calculated as mean±S.E for six rats in each group.
b
a
abc
ab
67
Normal HF HF+Pio(30) HF+GA(30) HF+GA(10)
Plasma HDL-C (mg/dL)
0 20 40 60 80
圖 5-9 灌食沒食子酸 4 週後大鼠於禁食情況下血漿中高密度脂蛋白濃度之變化。
Figure.5-9 Plasma high density lipoprotein levels of rats after 4 weeks feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~b Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
a
b
ab a
ab
68
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Glucose transporter 4 relative expression
0.0
Figure.5-10 Relative expression of glucose transporter 4 in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
a
c
ab a
bc
69
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10)
Insulin receptor relative expression
0.00
Figure.5-11 Relative expression of insulin receptor in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
a
c
b a
bc
70
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Protein kinase C -zeta relative expression
0 10 20 30 40
PKC-ζ(68KDa) α-tublin(55KDa)
圖 5-12 灌食沒食子酸 4 週後對大鼠腎周脂肪 PKC-ζ蛋白表現量之影響。
Figure.5-12 Relative expression of protein kinasein C-zeta in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
c
a
b
a
71
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Phosphofructokinase relative expression
Figure.5-13 Relative expression of phosphofructokinase in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
c
a
c
b
72
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Pyruvate kinase relative expression
0
Pyruvate kinase(62KDa)
α-tublin(55KDa)
圖 5-14 灌食沒食子酸 4 週後對大鼠腎周脂肪 PK 蛋白表現量之影響。
Figure.5-14 Relative expression of pyruvate kinase in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~b Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
a
b
b b
b
73
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Fatty acid synthase relative expression
0 1 2 3 4 5
FAS(273KDa)
α-tublin(55KDa)
圖 5-15 灌食沒食子酸 4 週後對大鼠腎周脂肪 FAS 蛋白表現量之影響。
Figure.5-15 Relative expression of fatty acid synthase in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~c Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
c
c
b a
c
74
Normal HF HF+PIO(30) HF+GA(30) HF+GA(10) Adipose triglyceride lipase relative expression
0.0
Figure.5-16 Relative expression of adipose triglyceride lipase in perirenal fat isolated from rats after 4 week feeding test.
Normal:Normal rats treated with saline HF: High fructose diet rats treated with saline
HF+Pio(30):High fructose diet rats treated with pioglitazone(30 mg/kg B.W.) HF+GA(30):High fuctose rdiet rats treated with gallic acid(30 mg/kg B.W.) HF+GA(10):High fructose diet rats treated with gallic acid(10 mg/kg B.W.) a~d Letter is significantly different among all samples tested( P< 0.05 ).
Values were calculated as mean±S.E for six rats in each group.
b
d
c a
d
75
圖 7-1、沒食子酸於脂肪細胞中調控醣類與脂質代謝之可能機制
Figure. 7-1 The postulated mechanism for gallic acid to regulate carbohydrate and lipid metabolism of adipocytes in high fructose diet-induced diabetic rats.
Glucose
Fat accumulation ↓
↑
76
行政院衛生署。2012。行政院衛生署衛生統計資訊網。http://www.doh.gov.tw 李雅婷。2004。酚酸衍生物之合成及其生物活性之研究。國立陽明大學。藥理學 treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem 261, 63-70.
Bhattacharya, S., Dey, D., and Roy, S.S. (2007). Molecular mechanism of insulin resistance. J Biosci 32, 405-413.
Birnbaum, M.J. 2001. Turning down insulin signaling. J Clin Invest 108: 655-659.
Brasaemle, D.L. (2010). Lipolysis Control: The Plot Thickens. Cell Metabolism 3, 173-174.
Bryant, N.J., Govers, R., and James, D.E. (2002). Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3, 267-277.
Calderhead, D.M., Kitagawa, K., Tanner, L.I., Holman, G.D., and Lienhard, G.E.
(1990). Insulin regulation of th e two glucose transporters in 3T3-L1 adipocytes.
J Biol Chem 265, 13801-13808.
Chavez, J.A., and Summers, S.A. (2003). Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419, 101-109.
Chirala, S.S., Jayakumar, A., Gu, Z.W., and Wakil, S.J.(2000). Human fatty acid synthase: Role of interdomain in the formation of catalytically active synthase dimer. PNAS 98, 3104–3108
Ciaraldi, T., and Henry, R.R. (1997). Thiazolidinediones and their effects on glucose
77 transporters. Eur J Endocrinol 137, 610-612.
Claus, T.H., Lowe, D.B., Liang, Y., Salhanick, A.I., Lubeski, C.K., Yang , L.L., Lemoine , L.L., Zhu , J., Clairmont, K.B. (2005). Specific Inhibition of Hormone-Sensitive Lipase Improves Lipid Profile while Reducing Plasma Glucose.
JPET 315:1396–1402.
Czech, M.P., and Corvera, S. (1999). Signaling mechanisms that regulate glucose transport. J Biol Chem 274, 1865-1868.
Day, C., Cartwright, T., Provost, J., and Bailey, C.J. (1990). Hypoglycaemic effect of Momordica charantia extracts. Planta Med 56, 426-429.
DeFronzo, R.A., and Ferrannini, E. (1991). Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes care 14, 173-194.
Delarue, J., and Magnan, C. (2007). Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10, 142-148.
Dey, D., Basu, D., Roy, S.S., Bandyopadhyay, A., and Bhattacharya, S. (2006).
Involvement of novel PKC isoforms in FFA induced defects in insulin signaling.
Mol Cell Endocrinol 246, 60-64.
Dresner, A., Laurent, D., Marcucci, M., Griffin, M.E., Dufour, S., Cline, G.W., Slezak, L.A., Andersen, D.K., Hundal, R.S., Rothman, D.L., et al. (1999). Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103, 253-259.
El-Kebbi, I.M., Roser, S., and Pollet, R.J. (1994). Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism 43, 953-958.
Erkelens, D.W. (2001). Insulin resistance syndrome and type 2 diabetes mellitus. Am J Cardiol 88, 38J-42.
Eriksson, J.W. (2007). Metabolic stress in insulin’s target cells leads to ROS accumulation –A hypothetical common pathway causing insulin resistance. FEBS Letters 581, 3734–3742.
J. Fanelli, C., Calderone, S., Epifano, L., De Vincenzo, A., Modarelli, F., Pampanelli, S., Perriello, G., De Feo, P., Brunetti, P., Gerich, J.E., et al. (1993). Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92, 1617-1622
Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. 1997. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 127(1):103-107.
Fievet, C., Fruchart, J.C., and Staels, B. (2006). PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome. Curr
78 Opin Pharmacol 6, 606-614.
Funaki, M., Randhawa, P., and Janmey, P.A. (2004). Separation of insulin signaling into distinct GLUT4 translocation and activation steps. Mol Cell Biol 24, 7567-7577.
Gao, X., Li, B., Jiang, H., Liu, F., Xu, D., and Liu, Z. (2007). Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia 78, 12-15.
Gesta, S., Bluher, M., Yamamoto, Y., Norris, A.W., Berndt, J., Kralisch, S., Boucher, J., Lewis, C. and Kahn, C.R. (2006) Evidence for a role of developmental genes in the origin of obesity and body fat distribution . Proc Natl Acad Sci 103:
6676-6681.
Goossens, G.H. (2008). The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94, 206-218.
Govers, R., Coster, A.C., and James, D.E. (2004). Insulin increases cell surface GLUT4 levels by dose dependently discharging GLUT4 into a cell surface recycling pathway. Mol Cell Biol 24, 6456-6466.
Hajduch, E.J., Guerre-Millo, M.C., Hainault, I.A., Guichard, C.M., and Lavau, M.M.
(1992). Expression of glucose transporters (GLUT 1 and GLUT 4) in primary cultured rat adipocytes: differential evolution with time and chronic insulin effect.
J Cell Biochem 49, 251-258.
Hoehn, K.L., Hohnen-Behrens, C., Cederberg, A., Wu, L.E., Turner, N., Yuasa, T., Ebina, Y., and James, D.E. (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7, 421-433.
Hsu, J.H., Wu, Y.C., Liu, I. M. and Cheng, J. T. (2007). Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. J Ethnopharmacol 112, 577-584.
Huang, H.L., Hong, Y.W., Wong, Y.H., Chen, Y.N., Chyuan, J.H., Huang, C.J., and Chao, P.M. (2008). Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 99, 230-239.
Huang, S., and Czech, M.P. (2007). The GLUT4 glucose transporter. Cell Metab 5, 237-252.
Hwei, W.P., Tsai, M.J., Hsu, C.Y., Wang, C.Y., Hsu, H.K., Weng, C.F.(2007). Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4.Food Chem Toxicol 7,2554-2560.
Iwu, M.M., Okunji, C.O., Ohiaeri, G.O., Akah, P., Corley, D., and Tempesta, M.S.
(1990). Hypoglycaemic activity of dioscoretine from tubers of Dioscorea dumetorum in normal and alloxan diabetic rabbits. Planta Med 56, 264-267.
79
Jakus, V., Sapak, M., Kostolanska, J.(2012)Circulating TGF-β1, Glycation, and Oxidation in Children with Diabetes Mellitus Type 1.Exp Diabetes Res,1-7
Jellinger, P.S., Mace, M.D.(2007). Metabolic Consequences of Hyperglycemia and Insulin Resistance. Clinical Cornerstone [Suppl 7]:S30–S42.
Jeon, J.R., Lee, J.S., Lee, C.H., Kim, J.Y., Kim, S.D., and Nam, D.H. (2006). Effect of ethanol extract of dried Chinese yam (Dioscorea batatas) flour containing dioscin on gastrointestinal function in rat model. Arch Pharm Res 29, 348-353.
Johnson, R.J., Perez-Pozo, S.E., Sautin, Y.Y., Manitius, J., Sanchez-Lozada, L.G., Feig, D.I., Shafiu, M., Segal, M., Glassock, R.J., Shimada, M., Roncal, C., and Nakagawa, T.(2009). Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes?Endocrine Reviews 30(1):96–116.
Jove, M., Planavila, A., Laguna, J.C., and Vazquez-Carrera, M. (2005).
Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 146, 3087-3095.
Kennedy, A., Martinez, K., Chuang, C.C., LaPoint, K., and McIntosh, M. (2009).
Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue:
mechanisms of action and implications. J Nutr 139, 1-4.
Khanna, P., Jain, S.C., Panagariya, A., and Dixit, V.P. (1981). Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod 44, 648-655.
Kim, H., Haluzik, M., Asghar, Z., Yau, D., Joseph, J.W., Fernandez, A.M., Reitman, M.L., Yakar, S., Stannard, B., Heron-Milhavet, L., et al. (2003). Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
Diabetes 52, 1770-1778.
Kumar, N., and Dey, C.S. (2002). Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells. Br J Pharmacol 137, 329-336.
Kumar, N., and Dey, C.S. (2003). Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells. Biochem Pharmacol 65, 249-257. Lawson, M.A., and Purslow, P.P. (2000). Differentiation of myoblasts in serum-free media: effects of modified media are cell line-specific. Cells Tissues Organs 167, 130-137.
Lee, C.C., Hsu, .W.H., Shen, S.R., Cheng, Y.H., Wu, .S.C.(2012). Fagopyrum tataricum (Buckwheat) Improved High-Glucose-Induced Insulin Resistance in Mouse Hepatocytes and Diabetes in Fructose-Rich Diet-Induced Mice.10, Exp Diabetes Res 375673-375683.
Lewis, G.F., Vranic, M., Harley, P., and Giacca, A. (1997). Fatty acids mediate the
80
acute extrahepatic effects of insulin on hepatic glucose production in humans.
Diabetes 46, 1111-1119.
Liao, W., Nguyen, M.T., Imamura, T., Singer, O., Verma, I.M., and Olefsky, J.M.
(2006). Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes. Endocrinology 147, 2245-2252.
Langin, D. (2006). Control of fatty acid and glycerol release in adipose tissue lipolysis.
Biologies 329 , 598–607
Liao, W., Nguyen, M.T., Yoshizaki, T., Favelyukis, S., Patsouris, D., Imamura, T., Verma, I.M., and Olefsky, J.M. (2007). Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 293, E219-227.
Liou, S.S., Liu, I.M., Hsu, S.F., and Cheng, J.T. (2004). Corni fructus as the major herb of Die-Huang-Wan for lowering plasma glucose in Wistar rats. J Pharm Pharmacol 56, 1443-1447.
Long, S.D., and Pekala P.H. (1996). Regulation of GLUT4 gene expression by arachidonic acid. J biol Chem 271, 1138-1144.
Lowell, B.B., and Shulman, G.I. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387.
Maury , E., and Brichard , S.M. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology 314, 1–16.
Marshall, S. (2006). Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Issue 346, p. re7
McAnuff, M.A., Harding, W.W., Omoruyi, F.O., Jacobs, H., Morrison, E.Y., and Asemota, H.N. (2005a). Hypoglycemic effects of steroidal sapogenins isolated from Jamaican bitter yam, Dioscorea polygonoides. Food Chem Toxicol 43, 1667-1672.
Mei, J., Wang, C.N., O''Brien, L., and Brindley, D.N. (2003). Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes. Int J Obes Relat Metab Disord 27, 31-39.
Michelle Furtado, L., Poon, V., and Klip, A. (2003). GLUT4 activation: thoughts on possible mechanisms. Acta Physiol Scand 178, 287-296.
Minokoshi, Y., Kahn, C.R., and Kahn, B.B. (2003). Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem 278, 33609-33612.
Moller, D.E. (2001). New drug targets for type 2 diabetes and the metabolic syndrome.
81 Nature 414, 821-827.
Ng, T.B., Li, W.W., and Yeung, H.W. (1989). Effects of lectins with various
Ng, T.B., Li, W.W., and Yeung, H.W. (1989). Effects of lectins with various